Astronaut loading animation Circular loading bar

Try : Insurtech, Application Development

AgriTech(1)

Augmented Reality(20)

Clean Tech(5)

Customer Journey(12)

Design(35)

Solar Industry(6)

User Experience(55)

Edtech(10)

Events(34)

HR Tech(2)

Interviews(10)

Life@mantra(11)

Logistics(5)

Strategy(17)

Testing(9)

Android(47)

Backend(30)

Dev Ops(7)

Enterprise Solution(27)

Technology Modernization(2)

Frontend(28)

iOS(43)

Javascript(15)

AI in Insurance(35)

Insurtech(63)

Product Innovation(49)

Solutions(19)

E-health(10)

HealthTech(22)

mHealth(5)

Telehealth Care(4)

Telemedicine(5)

Artificial Intelligence(132)

Bitcoin(8)

Blockchain(19)

Cognitive Computing(7)

Computer Vision(8)

Data Science(17)

FinTech(50)

Banking(7)

Intelligent Automation(26)

Machine Learning(47)

Natural Language Processing(14)

expand Menu Filters

Bridging the Gap between Social Enterprises and Social Impact Investors

socialentrepreneurship-2-1

Recently, I got the opportunity to participate in Bangalore CSR Roundtable hosted by Brillio & Equal Innovation in partnership with India CSR on May 3rd 2017.

Some key points from this event I want to share with you all. Before that let me put some light on what is Social Entrepreneurs and Enterprises (SEE) and how this is related to this event.

Social Entrepreneurs and Enterprises (SEE)

It is an initiative of IITK AA, organised and now carried forward in association with IITKGP AA and supported by PAN IIT, IIMA, PAN IIM and ACB.

SEE started as an event and the first SEE focused primarily on awareness and scaling models for Successful Social enterprises. It had speakers and participants from all sectors. During the first edition of SEE one message came out very clearly that there is an increasing gap between social enterprises (not-for-profit or for-profit) and CSR funds/investors.

Second edition of SEE focused on Healthcare and Education. This edition also looked at setting up the framework so that Alumni from IIT’s can effectively engage and contribute to the critical sector.

It brought various social entrepreneurs, philanthropists, thinkers and enthusiasts under one roof. The event allowed great interactive sessions where on one hand the participants got inspired by conviction-led work by speakers and on the other hand various corporate discussed the challenges and their insights. Mr. Paritosh Segal, Co-Founder Sahyog Foundation, led the curation for the event.

After intensive research on challenges faced by social enterprises and impact investors, a framework was launched during the event by Mr. Pradeep Bhargava, President, IITK AA & IITK AA BLR.  Core objectives of the framework is to identify sectors that may be relevant and that may produce visible outcome, list the key impact areas and the key measures, understand and share the feasibility and impact data, build the stakeholders connect as part of SEE ecosystem which comprises financial institutions, CSR, Angel investors, VC’s, mentors, incubation with IIT and partners and entrepreneurs in the impact space.

We discussed on various aspects of CSR funding and pain-points of corporates as well as social enterprises. It was very enthralling for me to know that all these common problems faced by both entities can be resolved through SEE platform.

I would like to highlight a few key challenges and would like to emphasise on the role of SEE framework in resolving these issues:

Lack of trust between corporates and social enterprise world:

It was evident that corporates are willing to release CSR funds for social enterprises, but whom to trust for measurable impact has become a challenge for them. I strongly believe that SEE body can recognise and validate shortlisted social enterprises who genuinely have good model and thus help them sustain and scale. Corporates can have concurrence and decide where to invest.

Impact assessment of social enterprises by corporates:

Second evident challenge for all corporates is to measure the impact created by the social enterprise. One of the solution which was proposed is to have a set template by corporates where social enterprise can fill their outcomes. But the problem with such template is that there are several different enterprises all cannot be measured with the same template. SEE framework can play a crucial role in impact assessment by providing customised template.

Industry standard reporting by social enterprises:

Another point which was brought into discussion was reporting structure and the quality of report. Corporates feel that there is a need for social enterprises to improve on reporting but the fact that social enterprises many a times are not trained to publish their reports in a professional way. It becomes really challenging for corporates to go through the document and validate the report. We at SEE aim to create a pool of identified experts in different domains with social sector background as mentors. These mentors shall bring guidance to social enterprises and shall organize hands-on training sessions on impact measurement, impact assessment and impact reporting. This shall have positive outcome by reducing frustrations for both corporates and social enterprises.

Identifying the key focus area of corporates by social enterprises:

One of the biggest challenge which almost all social enterprises face invariably is to find out the corporates who have same focus area as their own. I recently faced a problem in identifying a CSR who invest in healthcare area. There is no common platform where corporates list their focus areas and social enterprises list their work.

Participation as SEE evangelist

SEE platform has planned to create a database on SEE website for all participants. This is going to ease the very first step of corporate and social enterprise to find the best match.

Social Enterprises

All these and many more benefits can be obtained by signing up for SEE Framework. SEE as a part of Alumni framework is not chargeable. Please register to be part of the SEE ecosystem and all benefits.

Investment community and CSR support from Corporates

They can leverage the curated social enterprises. Investors and CSR teams may share the success stories, the impact areas of their interest and the measures they use in identifying the right enterprise to support.

Accelerators, Incubators, and Mentors ( AIM)

AIM participants work together with the SEE team to ensure high probability of success for the individual enterprise but also contribute to ensure a higher percentage of successful SE. Commercial engagements are also possible after the initial success is registered.

Look forward to you all being part of SEE

 

 

 

Cancel

Knowledge thats worth delivered in your inbox

Embracing the Digital Frontier: Transforming the Patient Journey in Pharma

In the realm of pharmaceuticals, the digital revolution is not just a buzzword; it’s a seismic shift reshaping the landscape of patient care. From discovery to delivery, digital technologies are revolutionizing every facet of the pharmaceutical industry. One of the most profound impacts is evident in the patient journey. Today’s Patients are more informed, engaged, and empowered than ever, thanks to the proliferation of digital tools and platforms. In this comprehensive exploration, we will delve into the multifaceted ways digital is redefining the patient journey in pharmaceuticals.

According to a report by Accenture on the rise of digital health, these are the key challenges to overcome:

  • 99% of respondents indicated that the development and commercialization of Digital Health solutions has accelerated in the past two years. As part of this, companies require various new and strengthened capabilities to execute their visions. 
  • Patients and health professionals need to trust that the data collected is accurate, safe, and secure for them to feel comfortable using it. 
  • Fragmented data or lack of access to data has been a barrier to development. An overarching guideline on data privacy is needed.

Leveraging Digital Solutions for Accessible Drug Delivery

In the pharmaceutical industry, the journey of medication from production facilities to patients’ hands is evolving with the integration of digital solutions. These technologies not only streamline logistics but also ensure that medications reach even the most remote and underserved areas. Let’s delve into how digital innovations are transforming drug delivery and backend channels in the pharmaceutical industry.

Digital Backend Channels and Supply Chain Management:

Pharmaceutical firms leverage digital tech for efficient backend operations. Software like SAP Integrated Business Planning and Oracle SCM Cloud enable real-time tracking, inventory management, and demand forecasting. With AI and analytics, companies adapt to market changes swiftly, ensuring timely medication delivery and optimized supply chain logistics.

Innovative Digital Drug Delivery Technologies:

  1. Controlled Monitoring Systems: Digital temperature monitoring systems provide digital temperature monitoring solutions using IoT sensors and cloud platforms, safeguarding temperature-sensitive medications during transit, ensuring compliance with regulatory standards, and minimizing product spoilage risk.
  1. Last-Mile Delivery Platforms: Zipline and Nimblr.ai, along with LogiNext, employ digital last-mile delivery solutions, using drones and AI-powered logistics to transport vital medical supplies efficiently to remote regions, improving accessibility for underserved communities.
  1. Telemedicine Integration with Prescription: Integrated telemedicine and prescription platforms, like Connect2Clinic, are rapidly growing in response to COVID-19. With telehealth claims at 38 times pre-pandemic levels, the industry is projected to hit $82 billion by 2028, with a 16.5% annual growth rate. Mantra Labs partnered with Connect2Clinic, enabling seamless coordination between healthcare providers, pharmacies, and patients. This facilitates virtual consultations and electronic prescribing, benefiting remote patients with medical advice and prescriptions without in-person visits. These platforms enhance healthcare access, medication adherence, and patient engagement through personalized care plans and reminders.
  1. Community Health Worker Apps: CommCare and mHealth empower community health workers with digital tools for medication distribution, education, and patient monitoring. Customizable modules enable tracking inventories, health assessments, and targeted interventions, extending pharmaceutical reach to remote communities, and ensuring essential medications reach those in need.

Through the strategic deployment of digital solutions in drug delivery and backend channels, pharmaceutical companies are overcoming barriers to access and revolutionizing healthcare delivery worldwide. By embracing innovation and collaboration, they are not only improving patient outcomes but also advancing toward a more equitable and inclusive healthcare system.

Personalized Medicine:

Wearable devices and mobile apps enable personalized medicine by collecting real-time health data and tailoring treatment plans to individual needs. For example, fitness trackers monitor activity and vital signs, customizing exercise and medication. Personalized medicine optimizes efficacy, minimizes adverse effects, and enhances patient satisfaction by leveraging patient-specific data.

Enhanced Patient Engagement:

Pharmaceutical firms utilize digital platforms for patient engagement, fostering support and education during treatment. Through social media, mobile apps, and online communities, patients connect, access resources, and receive professional support. Two-way communication enhances collaboration and decision-making, boosting treatment adherence, health outcomes, and consumer loyalty. Click here to know more.

Data-Driven Insights:

The abundance of healthcare data offers pharma companies unique opportunities to understand patient behavior and treatment patterns. By leveraging big data analytics and artificial intelligence, they extract actionable insights from various sources like electronic health records and clinical trials. These insights inform targeted marketing, product development, and patient support programs. However, ensuring data privacy and security is crucial, requiring robust regulatory frameworks and transparent practices in the digital era.

Challenges and Considerations:

Maximizing the benefits of digital technologies requires addressing challenges like patient data privacy and equitable access to healthcare tech. Stringent safeguards are needed to protect confidentiality and trust, alongside efforts to bridge the digital divide. Regulatory frameworks must evolve to balance innovation with patient safety and security amidst rapid advancements in digital health.

Key Considerations for Pharma Companies in Embracing Digital Innovation:

  • Prioritize patient-centricity in digital initiatives, focusing on improving patient outcomes and experiences.
  • Invest in robust data privacy and security measures to build and maintain patient trust.
  • Foster collaboration and partnerships with technology companies and healthcare providers to drive innovation and scalability.
  • Leverage analytics and AI to derive actionable insights from healthcare data and inform decision-making processes.
  • Continuously monitor and adapt to regulatory requirements and industry standards to ensure compliance and mitigate risks.

Conclusion:

The digital revolution is not just a paradigm shift but a catalyst for transformation across the pharmaceutical industry. By embracing digital technologies, pharma companies can unlock new opportunities to enhance the patient journey, improve treatment outcomes, and drive sustainable growth. However, realizing the full potential of digital health requires collaboration, innovation, and a steadfast commitment to addressing the challenges and considerations inherent in this transformative journey. As we navigate the digital frontier, the future of patient care promises to be more connected, personalized, and empowering than ever before.

Cancel

Knowledge thats worth delivered in your inbox

Loading More Posts ...
Go Top
ml floating chatbot